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BCL-2 modifying factor (BMF) is a sentinel 
considered to register damage at the 
cytoskeleton and to convey a death signal to 
B-cell lymphoma (BCL)-2. BCL-2 is 
neutralised by BMF and thereby facilitates 
cytochrome C release from mitochondria. 
We investigated the role of BMF for 
intestinal epithelial cell (IEC) homeostasis. 
Acute colitis was induced in Bmf deficient 
mice (Bmf-/-) with dextran sulfate sodium 
(DSS). Colonic crypt length in Bmf-/- mice 
was significantly increased as compared to 
wildtype (WT) mice. DSS induced less signs 
of colitis in Bmf-/- mice as weight loss was 
reduced compared to WT. Primary human 
IEC exhibited increased BMF in the 
extrusion zone. qPCR showed a significant 
upregulation of BMF expression after 
initiation of anoikis in primary human IEC. 
BMF was found on mitochondria during 
anoikis as demonstrated by Western. RNAi 
mediated knock down of BMF reduced the 
number of apoptotic cells and led to reduced 
caspase-3 activity. A significant increase in 
pAkt was determined after RNAi treatment. 
BMF knock down supports survival of IEC. 
BMF is induced in human IEC by the loss of 
cell attachment and is likely to play an 
important role in the regulation of IEC 
survival. 
 
Intestinal epithelial cells (IEC) are 
generated from stem cells at the base of the 
crypt and migrate on the underlying basement 
membrane towards the intestinal lumen in 3 to 
5 days, where apoptosis is initiated and cells 
finally lose anchorage and are shed into the 
lumen (1-4). IEC undergo apoptosis when they 
lose their contact with the extracellular matrix 
(5), a phenomenon termed “anoikis” (6). This 
special form of cell death is an important 
mechanism terminating the physiological life 
cycle of IEC (7-12). In contrast, carcinoma 
cells are resistant to anoikis, which is one of 
the pre-requisites for cancer development (13-
14). 
The activation of the apoptotic cascade 
leads to the cleavage of various structurally 
and functionally essential intracellular 
substrate proteins (15). We recently 
demonstrated that the preservation of cell-cell 
contacts and cell-matrix anchorage maintains 
both intercellular attachment and crypt 
structure diminishing initiation of the apoptotic 
cascade (16). Members of the B-cell 
lymphoma (BCL)-2 family of proteins decide 
over a cell’s life or death. BCL-2 is located on 
the outer mitochondrial membrane and 
prevents the release of cytochrome C from the 
mitochondrion. BCL-2 can interact with BMF 
(BCL-2-modifying factor), a member of the 
pro-apoptotic BH3-only protein subgroup of 
the BCL-2 family. BMF was first described in 
2001 (17) and initially discussed to transduce 
death signals caused by different forms of cell 
stress such as UV-irradiation or loss of contact 
to the extracellular matrix, i.e. anoikis, or 
inhibition of the CAP-dependent translation 
machinery (18). However, studies in different 
cell types from Bmf-deficient mice suggested 
redundancy with other BH3-only proteins 
during most of these cell death processes (19). 
BMF interacts intracellularly with the dynein 
light chain 2 (DLC2), a component of the 
myosin V motor complex. By this BMF can be 
separated from BCL-2. Some stress stimuli 
have been reported to induce the release of 
BMF from the complex and its translocation to 
mitochondria (17,20). Mutations in light-chain-
 binding domain of BMF enhance the death 
promoting activity of this protein in cell 
culture (17). BMF (as well as BAD, NOXA 
and PUMA) is also considered to act as 
sensitizer, which binds pro-survival BCL-2 
protein to displace activator BH3-only proteins 
(i.e. BID or BCL-2-interacting mediator of cell 
death (BIM)) from BCL-2 to promote cell 
death (21). The interaction of BMF with BCL-
2 on the mitochondrial surface neutralizes the 
anti-apoptotic action of BCL-2. Activator 
BH3-only proteins bind BAX and BAK, 
essential for mitochondrial apoptosis by 
forming pores in the mitochondrial membrane, 
and induce the release of cytochrome C finally 
triggering apoptosis. Alternatively, BMF may 
contribute to the neutralization of pro-survival 
proteins present in a cell, considered equally 
sufficient to induce apoptosis (22). 
BMF transduces death signals not only 
after release from the actin cytoskeleton, but 
also by activation of transcription. BMF 
transcription is induced by transforming 
growth factor- (TGF)-driven apoptosis in a 
number of cell types (23). TGF-induced 
autophagy potentiates the induction of the pro-
apoptotic proteins BMF and BIM by the stress-
responsive transcription factor CHOP upon 
growth factor withdrawal (24). Once BCL-2 is 
neutralized and cytochrome C is released out 
of the mitochondrion the so-called 
”apoptosome“ is built, inducing a proteolytic 
cascade of caspases (25-29). During anoikis of 
human IEC, caspases-2 and -9 are reportedly 
involved in the initiation of anoikis and 
activate downstream effector caspases-7, -3 
and -6 (30). This results in a sequential 
cleavage of focal adhesion kinase (FAK) by 
caspase-3 and caspase-6 (31) and culminates in 
characteristic apoptotic morphological 
changes.  
Together, this suggests that BMF may be 
critical for epithelial cell homeostasis. We 
investigated the role of BMF for cell death of 
IEC in mice under inflammatory conditions as 
well as in isolated primary human IEC. 
 
Experimental Procedures 
 
Patients- Primary human IEC were obtained 
from surgical specimens from intestinal 
mucosa of 62 patients undergoing surgery in 
the large or small bowel (> 10 cm distance 
from the tumor for carcinoma patients, 
supplemental table 1). 34 were male and 28 
were female. Patients were between 17 and 89 
(mean 51  17) years of age. This study was 
approved by the Ethics Committees of the 
University of Regensburg and the University 
of Zurich and performed according to the 
declaration of Helsinki.  
 
Induction and treatment of dextran sulfate 
sodium (DSS) colitis- Male C57BL/6-
Bmftm1.1Anvi (Bmf-/-) mice were backcrossed for 
at least 12 generations (19). Mice weighing 25-
32 g were used for the experiments and housed 
in individually ventilated cages. Acute colitis 
was induced as described previously (32). 
During induction of acute colitis mice received 
either 3.5 % DSS in drinking water or drinking 
water alone over eight days. Animals were 
provided unlimited access to food and water 
throughout the experiment (ad libitum). Mice 
were killed on day eight. From the distal third 
of the colon, 1 cm of colonic tissue was 
removed and used for histological analysis, as 
described previously (32-33).  
 
Cell lines, IEC isolation and induction of 
anoikis- Cells were grown in RPMI 1640 (Bio 
Whitaker, Verviers, Belgium) supplemented 
with 10 % fetal calf serum (FCS), 100 U/ml 
penicillin, 100 µg/ml streptomycin and 2 mM 
L-glutamine (GIBCO, Invitrogen cell culture, 
Vienna, Austria) at 37ºC, 5 % CO2. HEK293T 
packaging cells for lentivirus production were 
grown in DMEM (BioWitthaker) containing 
10 % FCS, 100 U/ml penicillin, 100 µg/ml 
streptomycin and 2 mM L-glutamine 
(GIBCO).  
IEC were isolated as described in (34) and 
in the supplement. For induction of 
anoikis, IEC were liberated from crypts by 
agitation at 37°C on a whip-shaker.  
 
Antibodies- Primary antibodies: Rat anti-
BMF IgG2a (#9G10, Alexis, Lörrach, 
Germany, 1:500), rabbit anti-human BMF 
(#ab59906, abcam, 1:100), rabbit anti-cleaved 
caspase-3 (Asp175, #9661, Cell signalling 
Technology, Beverly, MA, 1:3000), mouse 
anti-caspase-3 IgG2a (#610322, BD, 
Lexington, KY, 1:3000), rabbit anti-pAKT 
(#9271, Cell Signaling, 1:1000), mouse anti-
caspase-6 IgG1 (#556581, BD, 1:1000), rabbit 
anti-cleaved caspase-6 (#9761, Cell Signaling, 
1:1000), mouse anti-caspase-7 IgG1 (#9494, 
Cell Signaling, 1:1000), mouse anti-human 
cytochrome C oxidase; mitochondria complex 
(COX) IV (#MS408, Acris, 1:2000) and mouse 
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 anti-β-actin IgG1 (#sc8432, Santa Cruz, 
1:10 000).  
Isotype controls: rat IgG2a (#ab18450, 
Abcam, Cambridge, UK), rabbit and mouse 
IgG (sc-2027 and sc-2025, Santa Cruz). 
Secondary antibodies: Alexa Fluor 488 goat 
anti-rat IgG (#A11006, Molecular Probes OR, 
USA, 1:300), goat anti-rat IgG, goat anti-rabbit 
IgG and goat-anti-mouse IgG (IgG-HRP, sc-
2006, sc-2004, sc-2005, Santa Cruz, 1:5000) 
 
Digitonin-based subcellular fractionation 
and Western- For isolation of mitochondria, 
IEC (3 x 107) were washed in ice cold PBS. 
Cells were digitonin-permeabilized in 1 ml 
cytosolic extraction buffer (200 µg/ml 
digitonin, #D141, Sigma, and a complete mini 
tablet, #04 693 124 001, Roche, Mannheim, 
Germany, in 250 mM sucrose, 70 mM KCl, 
137 mM NaCl, 4.3 mM Na2HPO4, 1.4 mM 
KH2PO4, pH 7.2). Plasma membrane 
permeabilization of cells was confirmed by 
staining in a trypan blue solution. Cells were 
centrifuged at 1000 g for 5 min at 4°C. The 
supernatant (cytosolic fraction) was saved and 
the pellets were solubilized in the same volume 
of mitochondrial lysis buffer (50 mM Tris, 
150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 
0.2 % Triton X-100, 0.3 % NP-40 and a 
complete mini tablet, pH 7.4), followed by 
pelleting at 10 000 g for 10 min at 4°C. The 
supernatant was collected as mitochondrial 
fraction. Western was performed as described 
in the supplement and in (16). 
 
Virus generation and Transfection- Vector 
cloning and infections were performed as 
described in the supplement and in (35). 
Human mucosa for viral transduction was 
transferred immediately after surgery in the 
viral supernatant. Isolation of intestinal crypts 
was performed in lentivirus-containing media. 
Isolation was finished within a time period of 
1.5 hours. Crypts were then kept on collagen-
coated transwells at 37°C, 5 % CO2 in 
lentivirus-containing media. After 24 hours on 
transwells, IEC were isolated. Including the 
transport of the resection from the department 
of surgery IEC were kept in virus containing 
media for 25.5 hours. After 25.5 hours, IEC 
were isolated.  
 
Statistical analysis- Real time PCR data 
were calculated from triplicates. Statistical 
analysis was performed using the Mann-
Whitney rank sum test. One-Way ANOVA test 
was used for body weight, colon length and 
real time PCR if four groups were compared. 
Mann-Whitney rank sum test was used for 
crypt length, real time PCR if two groups were 
compared, Western blot. Data are expressed as 
mean ± S.D. Differences were considered 
significant at p < 0.05 (*), highly significant at 
p < 0.01 (**) and very highly significant at 
p < 0.001 (***). For statistical analysis of 
Westerns, luminescence signals were 
determined by densitometry and quantified 
with the OptiQuant software (Packard 
Instrument, Meriden, CT, USA). 
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 Results 
 
Crypt structures are protected in Bmf-/- 
mice upon DSS-colitis. We focused on the 
involvement of BMF in inflammatory 
responses and its property to induce apoptosis 
in IEC. Colonic crypt lengths for Bmf-/- mice 
were significantly increased compared to 
wildtype (156.9  32.0 µm, n = 99 and 
139.8  22.4 µm, n = 96, calculated from 
sections of 5 mice respectively, p < 0.05, 
figure 1A - C). A hydrometrocolpos was 
described in female Bmf-/- mice. Confirmative 
to this, we observed an enlarged uterovaginal 
tract in Bmf-/- mice. 
We used the DSS colitis mouse model to 
determine BMF-dependence of mucosal 
inflammation. During induction of acute colitis 
mice received 3.5 % DSS in drinking water 
(n = 10) or drinking water alone (n = 10) over 
eight days. Water consumption was not 
reduced in mice treated with DSS (126 ml for 
Bmf-/- mice with DSS, 121 ml for Bmf-/- mice 
with water, 119 ml for wildtype with DSS and 
122 ml for wildtype with water, n = 5 each). 
Upon DSS, weight loss of Bmf-/- mice was 
significantly decreased from day five to eight 
compared to wildtype mice (figure 1D). Upon 
DSS, no blood was visible on the anus of Bmf-/- 
mice, whereas two wildtype mice displayed 
blood on the anus from day four to day eight 
and four wildtype mice displayed blood on the 
anus from day five to day eight. Upon DSS, no 
aggressive behavior was observed in cages 
with Bmf-/- mice, whereas wildtype mice 
showed aggressive behavior from day four to 
day eight. Induction of colitis was followed by 
a typical and significant reduction of colon 
length (supplemental figure 1A and B). Bmf-/- 
mice with and without colitis showed an 
increased colon length.  
Previous experimental evidence reported 
impaired cell death in lymphocytes in the 
absence of BMF, but no significant differences 
between wildtype and Bmf-/- mice IEC 
undergoing cell death in vitro were noted (19). 
Consistently, we failed to observe differences 
in the histological score between Bmf-/- and 
wildtype mice receiving water (0.9  0.4 for 
Bmf-/- mice and 1.3  0.8 for wildtype mice, 
n = 5 each). The histological score for Bmf-/- 
mice and wildtype mice receiving DSS was 
also not significantly altered (7.6 ± 0.4 and 
7.4 ± 0.7 respectively). 
To locate apoptotic cells in colonic tissue we 
performed TUNEL analysis. Cleavage of 
genomic DNA during apoptosis was found in 
an expected dimension. Apoptosis was not 
uniform along the crypt-villus axis. In crypts, 
positively stained cells were preferentially 
detected apically, close to the lumen. 
Confirmative to previous findings based on 
FACS analysis, TUNEL staining revealed no 
decrease in apoptosis from colonic IEC lacking 
BMF in situ (supplemental figure 1C - F). 
Mucosa from mice suffering from DSS colitis 
showed an extensive epithelial damage and 
both infiltration and thickening of the mucosa. 
In wildtype and Bmf-/- mice receiving DSS, 
crypt morphology was absent and goblet cells 
were lost. To detect remaining IEC, EpCAM 
staining was performed. 45  37 % of IEC 
remained as a layer on the thickened mucosa of 
the distal end of the colon in Bmf-/- mice upon 
DSS compared to 34  33 % in DSS-treated 
wildtype mice (supplemental figure 1G and H).  
 
BMF expression is induced along the 
human crypt-villus axis. IEC mature along the 
crypt-villus axis. Maturation is reflected in 
both changes of gene expression and transition 
from an epithelial stem cell, firmly embedded 
in the crypt, to a cell intrinsically prone to 
anoikis and prepared to be detached. BMF on 
mitochondria results in cytochrome C release 
from mitochondria and activation of the 
caspase cascade leading to apoptosis. 
Immunohistochemistry (IHC) was performed 
to localize BMF in human colonic sections. 
IEC exhibited intense staining in the extrusion 
zone where cells are expected to be shed. 
Brown staining was found in IEC in human 
mucosa (figure 2A - B). IEC were isolated 
from patients by three successive agitation 
procedures. Single cells were separated from 
whole crypts and the relative amount of BMF 
cDNA was calculated by means of real time 
PCR. Data from crypts were set to 1. BMF 
mRNA in single IEC from patients without 
inflammatory bowel disease (IBD) was 
2.2  2-fold increased compared to crypts 
(figure 2D). BMF mRNA in single cells from 
patients with IBD was significantly increased 
(4.8  1.5-fold, Mann-Whitney rank sum test, 
p < 0.05) compared to crypts. The same trend 
was found for PUMA and BID without 
reaching statistical significance (supplemental 
figure 2A and B). Human IEC are fractionated 
during the isolation procedure according to 
their capacity of staying attached to the colonic 
mucosa. BMF mRNA is downregulated in IEC 
obtained in second and third fractions (figure 
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 2E). Data from the first IEC fraction of each 
surgical specimen were set to 100 %. 
Significant differences were determined 
between the first and the second crypt fraction 
(-66  32 %) and the first and the third fraction 
of single cells (-29  3 %, ANOVA multiple 
variance analysis, p < 0.05).  
 
BMF is upregulated and found on 
mitochondria during anoikis. Anoikis is the 
inevitable end of the IEC life cycle. Anoikis is 
also inducible by disconnecting cell-cell and 
cell-matrix contacts as described in materials 
and methods. Real time PCR was performed 
from freshly isolated human IEC and detached 
IEC, 2 h after ex-vivo isolation from 19 
surgical specimens. The initiation of anoikis is 
followed by a significant upregulation of BMF 
mRNA (p < 0.05, figure 3A). Significant 
upregulation was found for PUMA 
(supplemental figure 3, Mann-Whitney Rank 
Sum Test. P < 0.05).  
We examined BMF level in mitochondria 
from human IEC after the induction of anoikis. 
Cells from the last of the three successive 
agitation procedures were used. Mitochondria 
were prepared from freshly isolated IEC and 
from IEC incubated without matrix contact for 
2 h after ex-vivo isolation. Figure 3B shows 
BMF in the mitochondrial fraction 2 h after 
induction of anoikis (23 and 25 kDa, upper 
box). This could be due to higher expression 
levels. Immediately after isolation of IEC, 
BMF was barely visible in the mitochondrial 
fraction.  
 
Knock down of BMF reduces anoikis in 
human IEC. Anoikis is initiated following 
neutralization of the anti-apoptotic BCL-2 
proteins through association of BMF and/or 
other BH3-only proteins. HEK293T were 
transfected for virus assembly. Development of 
virus in supernatants and efficient transduction 
was confirmed (supplemental material, figure 
4A - E). Including the transport of the 
resection from the department of surgery, 
isolation of crypts and incubation on transwells 
IEC were kept in virus containing media for 
25.5 hours. Efficient infection of human 
crypts, kept on collagen coated transwells, was 
confirmed by fluorescence microscopy (figure 
4A). Viability of IEC was confirmed by trypan 
blue staining (figure 4B). Knock down of BMF 
in IEC was confirmed by determining BMF 
with Western (figure 4C). Efficient 
downregulation of BMF mRNA in infected 
IEC was confirmed by real time PCR. Mock-
infected IEC had a BMF / GAPDH ratio of 
8.0  5.8 (n = 3) and virus-infected cells had a 
BMF / GAPDH ratio of 0.2  0.2 (n = 3). We 
investigated, whether knock down of BMF by 
the lentiviral system is able to delay anoikis in 
human IEC. For fluorescence microscopy cells 
were mounted with medium containing DAPI. 
Freshly isolated human IEC displayed round 
shaped nuclei revealing no indication of 
anoikis (figure 4D). To induce anoikis single 
IEC were liberated from isolated crypts by 
agitation at 37°C on a whip-shaker in media 
including EDTA for 2 h and harvested by 
centrifugation. Fluorescence microscopy 
showed cells with a disintegrated nuclei 
pattern, a clear sign of ongoing execution of 
anoikis (figure 4E). No round shaped nuclei 
were found. Figure 4F shows cells with BMF 
knock down 2 h after induction of anoikis. The 
number of apoptotic nuclei was lower than in 
the experiments without knock down as a 
number of round shaped nuclei were found. 
These data show that BMF knock down in 
human IEC is capable of preserving cellular 
morphology. 
 
Knock down of BMF maintains 
phosphorylation of Akt and blocks activation of 
caspases. Including the transport of the 
resection from the department of surgery, 
isolation of crypts and incubation on transwells 
IEC were kept in virus containing media for 
25.5 hours. Phosphorylation of the important 
pro-survival signaling molecule AKT in 
human crypts, isolated within the first fraction 
of IEC, was determined by Western. AKT 
reportedly promotes cell survival by inhibiting 
anoikis via phosphorylation and inactivation of 
several proapoptotic targets including BAD 
and caspase-9 (16). Phosphorylation, and 
thereby activation, of the protein kinase AKT 
was detectable by Western at 60 kDa (pAKT). 
After BMF knock down AKT was found in an 
activated state in IEC, kept on collagen-coated 
transwells for 24 hours while pAKT levels in 
dying mock-infected cells were clearly lower 
(figure 5A). This indicates that survival 
pathways can be maintained efficiently when 
cells are protected from apoptosis due to lack 
of BMF. Following the studies on 
fragmentation of the nuclei, we addressed the 
impact of BMF knock down on the activation 
of caspases, as execution of the caspase 
cascade initiates degradation of DNA. To 
investigate the effect of BMF knock down, 
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 caspase-3 activation in response to induction of 
anoikis in whole crypts of human IEC with and 
without BMF knock down was determined by 
Western (figure 5B). Mock-treated IEC 
showed increased levels of active caspase-3, 
illustrating ongoing apoptosis.  
Next, the lentiviral system was used to 
knock down BMF in whole resections of 
human colonic mucosa. Again, the incubation 
with virus-containing medium was 
immediately started after the surgery. In this 
experiment, after six hours of incubation in 
lentivirus containing medium, human IEC 
were isolated and kept for two hours on a 
whip-shaker for induction of anoikis. Cleavage 
of caspase-3 was determined in single cells 
from the first agitation step (figure 5C). IEC 
liberated from the basal lamina showed 
significantly higher levels of activated caspase-
3 after mock infection compared to cells with 
BMF knock down (n = 6, Mann-Whitney rank 
sum test was performed, p < 0.05). This 
indicates decreased activation of death signals 
after BMF knock down.  
Cleavage of caspase-6 and -7 was 
determined in lysates from cells collected after 
the first agitation step (figure 5D). Here, IEC 
were again kept in virus containing media for 
25.5 hours. Western for inactive procaspase-6 
(35 kDa) and procaspase-7 (35 kDa) 
demonstrated that both proteases were 
activated more effectively in the mock infected 
group. Next, we performed Western for 
activated caspase-3 in IEC of the first, second 
and third agitation steps with and without BMF 
knock down (figure 5E). Treatment with RNAi 
for BMF knock down led to lower amounts of 
active caspase-3. Taken together, these 
experiments demonstrate that activation of 
caspases is delayed by BMF knock down. 
 
Discussion 
 
In the present study, we show that down-
regulation of BMF suppresses anoikis in 
primary human IEC in vitro. In a second 
attempt we used the DSS-colitis mouse model 
to determine BMF-dependence of mucosal 
inflammation. Upon DSS weight of Bmf-/- mice 
was significantly increased compared to 
wildtype. Bmf-/- mice with and without colitis 
showed an increased colon length. Crypt 
lengths for Bmf-/- mice receiving water were 
significantly increased compared to water-
treated wildtype mice. A possible explanation 
for an increased colon and crypt length could 
be that the lifespan of IEC in Bmf-/- mice is 
longer than in wildtype mice. The proportion 
of apoptotic IEC compared to the number of 
total cells in a crypt could be lower in Bmf-/- 
mice, synonymic with a decreased apoptosis 
rate of IEC in Bmf-/- mice. A decreased 
apoptosis rate and unchanged number of dead 
cells in a crypt at the same time could 
contribute to elongation of crypts. This could 
be protective during onset of inflammation. 
The histological score for Bmf-/- mice and 
wildtype mice receiving either water or DSS, 
however, was not significantly altered at the 
end of the experiment. Both water-treated 
groups showed almost no signs of 
inflammation. Mice from both DSS treated 
groups were severely inflamed at the distal end 
of the colon. Differentiation between both 
groups was not possible with this parameter. 
Human colonic IEC exhibited intense 
staining in the extrusion zone. Expression of 
BMF in IEC was confirmed by real time PCR. 
The technique utilized to isolate IEC requires 
several successive agitation procedures to 
discriminate discrete fractions. In consequence 
of the isolation procedure both single cells and 
whole crypts embedded more loosely in the 
mucosal architecture are supposed to be 
isolated earlier during the procedure. Adhesion 
of IEC to the basal lamina is not uniform along 
the crypt-villus axis. Molecules regulated 
between crypt and villus, like tenascin and 
cellular fibronectin, are able to modify cellular 
adhesion and play a role in IEC shedding 
(7,10). Experimental induction of anoikis in 
human IEC was followed by a significant 
upregulation of BMF. We showed that protein 
levels increase in the mitochondrial fraction 
upon induction of anoikis in human IEC in 
vitro. This could be due to higher expression 
levels or translocation. Detachment of IEC, the 
trigger of anoikis, is associated with BMF 
upregulation. Cell death is initiated following 
neutralization of BCL-2 or homologues 
through association of BMF. We performed 
knock down of BMF to determine if cell 
survival could be prolonged. Knock down of 
BMF is able to delay anoikis in human IEC as 
shown with several assays: Fluorescence 
microscopy revealed a preserved morphology 
of the nuclei in knock down experiments. 
Activation of the downstream effector caspases 
3, 6 and 7 is decreased as determined by 
Western. The signaling molecule Akt remained 
in an active state, indicating that the 
corresponding survival pathways were 
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maintained. Caspase-3 was activated in all 
single IEC suspensions but the most prominent 
effect of BMF knock down was determined in 
the third agitation fraction. These experiments 
confirmed differences in successive IEC 
fractions and indicate that in the latter fraction 
BMF is decreased and anoikis is least 
advanced. 
Similar to our experiments Schmelzle et al. 
investigated the role of BMF in mammary 
epithelial anoikis (36). In mammary epithelial 
cells anoikis is induced by detachment from 
the matrix as in assays performed in the study 
presented here with colonic IEC. Interestingly, 
mRNA levels of BMF are up-regulated during 
anoikis upon loss of matrix attachment. Down-
regulation of BMF expression by RNAi 
mediated knock down is sufficient to prevent 
anoikis.  
BIM, another pro-apoptotic BH3-only 
protein family member, also interacts with the 
pro-survival family member BCL-2. BIM is 
functionally required for anoikis and a 
knockdown of BIM also prevents cell death 
(36). BMF is sequestered to the myosin V 
motor complex (17) and BIM to microtubule 
complexes (37), both cytoskeleton-associated 
structures. Both seem to monitor cytoskeletal 
integrity. Both proteins counteract the 
apoptotic activity of pro-survival BCL-2 when 
vital processes are disturbed. Maturation of 
IEC along the crypt-villus axis might be 
defined by different aspects. The spatial 
arrangement of a cell within a crypt, the 
genetic programming during maturation (38), 
the preservation of cell-cell contacts and cell-
matrix anchorage (16), cellular remodelling or 
the intracellular damage status of a cell might 
contribute to the fate of a cell. Inhibition of 
BMF seems to be a possible medication for 
epithelial lesions. But others reminded the 
possibility that deletion of BMF would allow 
survival of tumor cells deprived of matrix 
interactions outside their natural "niche" (36). 
BMF was suggested as putative tumor 
suppressor gene in epithelial solid tumors 
because it is located on chromosome 15q14 
(39), a site frequently lost in metastatic colon 
cancer, and actively prevents formation of c-
myc driven lymphomas. 
In summary, this work describes the 
sequence of intracellular events during anoikis, 
a physiological form of apoptosis, in a 
population of primary human IEC. Our studies 
narrow down the initiating event leading to the 
activation of anoikis. Given the stronger 
expression of pro-survival BCL-2 family 
members in IEC at the base of the intestinal 
crypt (40) future studies are underway to 
delineate the reciprocal expression of its 
antagonist BMF and BIM.  
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 FIGURE LEGENDS 
 
 Fig. 1. Crypt length and body weight loss. Crypt lengths for (A) Bmf-/- mice receiving water and 
(B) wildtype mice receiving water. Section 0 - 1 cm from the distal end of the colon. (C) Normality 
test for crypt length in Bmf-/- mice and wildtype mice receiving water failed and Mann-Whitney rank 
sum test was performed. Bmf-/- mice showed a significant increased crypt length compared to wildtype 
mice. P < 0.001. (D) Bmf-/- mice (circles) and wildtype mice (triangles) received either DSS (filled) or 
water (empty). Bars represent mean ± s.d. One-Way ANOVA test was used. Body weight loss was 
significantly different for wildtype mice upon DSS compared to Bmf-/- mice upon DSS on day 5, 6, 7 
and 8. Day 5 P = 0.016, day 6 P = 0.008, day 7 P = 0.007 and day 8 P = 0.016, n = 5 each. Bmf-/- mice 
showed a significant decreased body weight loss upon DSS and increased crypt length upon water. 
 
 Fig. 2. IHC for BMF on sections from human (A, B) large intestine and (C) small intestine. (A and 
B) Immunostaining of BMF on section from a Crohn’s disease patients without inflammation. (C) 
Negative control without primary antibody. IHC revealed an expression gradient of BMF along the 
crypt-villus axis. DAB procedure. Original magnification (A and C) × 100, (B) × 200. (D) BMF is 
significantly increased in single IEC from IBD patients compared to crypts. (E) BMF is downregulated 
in IEC isolated in subsequent agitation procedures in both single cells and crypts. IEC were isolated by 
three successive agitation procedures and BMF expression was analyzed by real time PCR. One-Way 
ANOVA test was used. * P < 0.05. 
 
Fig. 3. Initiation of anoikis is followed by upregulation of BMF. (A) Real time PCR of freshly 
isolated human IEC and human IEC 2 hours after ex-vivo isolation. Mann-Whitney rank sum test was 
performed. P < 0.05. n=19, ## = median. (B) Western of mitochondrial fractions of freshly isolated 
IEC and IEC 2 hours after ex-vivo isolation. A third BMF isoform seen in human IEC lysates was not 
detected in extracts from mouse spleen used as positive control. Western for COX IV (18 kDa) 
showed successful purification of mitochondria and demonstrates equal loading in the human IEC 
samples analyzed but, as expected was not detected in the mouse extract due to specificity to the 
human protein (lower box). Loss of cytochrome C (15 kDa) was only marginal 2 h after ex-vivo 
isolation (not shown). Data representative for three patients. 
 
Fig. 4. Knock down of BMF in primary human IEC crypts. Including the transport of the resection 
from the department of surgery, isolation of crypts and incubation on transwells IEC were kept in 
virus containing media for 25.5 hours. (A) Fluorescent image of crypts infected with lentivirus. (B) 
Transmission light microscopic image of crypts, cultivated on collagen coated transwells and 
incubated with trypan blue. (C) Western and densitometry confirms downregulation of BMF. (D) 
Fluorescence microscopy of freshly isolated cells, (E) cells 2 hours after induction of anoikis and (F) 
cells with BMF knock down 2 hours after induction of anoikis. Knock down of BMF protects against 
condensation of chromatin. DAPI, x 630. Data representative for three patients. 
 
Fig. 5. Knock down of BMF maintains active form of pro-survival factor AKT and inactive form 
of caspase-3 in primary human IEC. In (A, B, D and E) IEC were kept in virus containing media for 
25.5 hours. (A) pAKT after induction of anoikis in whole crypts with and without BMF knock down. 
(B) Cleaved caspase-3 after induction of anoikis in whole crypts with (left) and without BMF knock 
down (right). Cleaved caspase-3 was normalized to caspase-3 proform. (C) After six hours of 
incubation in lentivirus containing medium cleaved caspase-3 after induction of anoikis in single cells 
with (left) and without BMF knock down (right), Mann-Whitney rank sum test was performed, 
p < 0.05, n = 6. Patients are not identical to those used in figure 5B. Cleaved caspase-3 was 
normalized to -actin. (D) Knock down of BMF maintains inactivated caspases 6 and 7 in single cells. 
Data representative for three patients.  
(E) Western for activated caspase-3 from IEC of the first, second and third agitation procedure 
with and without BMF knock down. IEC from 3 patients were isolated and anoikis was induced in 
both whole crypts (left) or in single cell suspension (right). Western for -actin demonstrated equal 
loading of the samples. In the isolated, intact crypts, caspase-3 was activated independent of RNAi 
treatment in crypts from the first and second agitation procedure (4228 and 1853 density units 
respectively in the blot shown). Mann-Whitney rank sum test was performed. In both cases treatment 
10 
 with RNAi led to significantly less active caspase-3 (53  21 and 74  39 % compared to untreated 
cells respectively, n = 3, p < 0.05). In cells from the third agitation procedure no activated caspase-3 
was detectable. In isolated single IEC caspase-3 was activated without RNAi treatment in the 
suspension from all three agitation procedures (3275, 883 and 319 density units respectively in the blot 
shown). BMF knock down led to significantly reduced caspase-3 activity in single IEC from the first 
and the second agitation procedure (82  57 and 70  30 % compared to untreated cells respectively, n 
= 3, p < 0.05). In cells from the third agitation procedure no activated caspase-3 was detectable. Whole 
crypts and single cells were isolated by three successive agitation procedures. Data representative for 
six patients. 
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